Analysis of factors predicting the response to tolvaptan in patients with liver cirrhosis and hepatic edema
Journal of Gastroenterology and Hepatology Dec 11, 2017
Atsukawa M, et al. - The factors predictive of treatment response to tolvaptan (V2-receptor antagonist) for cirrhotic patients with hepatic edema were explained in a real-world setting. Among cirrhotic patients with hepatic edema, blood urea nitrogen (BUN) level and urinary sodium excretion were closely associated with the response to tolvaptan.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
